H.R.1142 Amending the Public Health Service Act for Drug Adherence Guidelines

Proposed 2025-02-07 | Official source

Summary

Requires the Secretary of Health and Human Services to establish drug adherence guidelines using artificial intelligence and machine learning, aiming for 90% adherence for Medicare Part B and D drugs. Promotes usage of generic and biosimilar drugs.

This machine-generated summary is awaiting review by an AGORA editor. Use with caution.
This document has not been enacted or otherwise finalized and is subject to change. This summary is based on a copy of the document collected 2025-04-22 - refer to the official source for the most current version.

Key facts

🏛️ This document has been proposed by the United States Congress, but is not yet enacted. For authoritative text and metadata, visit the official source.

📜 This document's name is H.R.1142 - To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.. AGORA also tracks this document under the name H.R.1142 Amending the Public Health Service Act for Drug Adherence Guidelines.

Themes AI risks, applications, governance strategies, and other themes addressed in AGORA documents.

This document has not been enacted or otherwise finalized and is subject to change. This summary is based on a copy of the document collected 2025-04-22 - refer to the official source for the most current version.

Thematic tags are in progress.

Full text

This is an unofficial copy. The document has been archived and reformatted in plaintext for AGORA. Footnotes, tables, and similar material may be omitted. For the official text, visit the original source.
This text may be out of date. According to the latest data in AGORA, this document has been proposed, but is not yet enacted or otherwise finalized. This text was collected 2025-04-22 and may have been revised in the meantime. Visit the official source for authoritative text.

A BILL To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Establishment of drug adherence guidelines. Title XVII of the Public Health Service Act (42 U.S.C. 300u et seq.) is amended by inserting after section 1711 (42 U.S.C. 300u–16) the following: “SEC. 1712. Establishment of drug adherence guidelines. “(a) In general.—The Secretary shall establish drug adherence guidelines with the goal of achieving 90 percent adherence for all Medicare part B and D drugs.

“(b) Contents.—In establishing the guidelines under subsection (a), the Secretary shall— “(1) incorporate artificial intelligence and machine learning technologies; and “(2) to the maximum extent practicable, promote the use of generic and biosimilar drugs.

“(c) Definitions.—In this section: “(1) MEDICARE PART B DRUG.—The term ‘Medicare part B drug’ means a drug or biological product for which payment may be made under part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.). “(2) MEDICARE PART D DRUG.—The term ‘Medicare part D drug’ means a covered part D drug (as defined in section 1860D–2(e) of the Social Security Act (42 U.S.C. 1395w–102(e))).”.